NEW YORK (360Dx) – Roche announced late Friday that it has received US Food and Drug Administration clearance for its Elecsys Anti-Müllerian hormone (AMH) assay.

According to the company, the assay is the first approved fully automated AMH test available in the US. Roche said that the assay was approved via the FDA's de novo classification option.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.